Stay updated on RT+Nivolumab+Ipilimumab vs RT+Capecitabine Clinical Trial
Sign up to get notified when there's something new on the RT+Nivolumab+Ipilimumab vs RT+Capecitabine Clinical Trial page.

Latest updates to the RT+Nivolumab+Ipilimumab vs RT+Capecitabine Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page revision was updated to v3.4.3, adding status metadata and sponsor attribution (Centre Leon Berard). The previous revision was v3.4.2.SummaryDifference0.4%

- Check17 days agoChange DetectedPublication citation updated from Breast 2025 Online Ahead of Print to Breast 2026 Feb final publication, with the final date now shown.SummaryDifference0.0%

- Check32 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no user-facing content changes detected on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check39 days agoChange DetectedMinor revision tag updated from v3.4.0 to v3.4.1; no changes to study content or user-facing functionality detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check54 days agoChange DetectedUI changes add glossary toggle options (Show glossary / Hide glossary) and update the page version to Revision: v3.4.0, while minor text changes adjust QC labeling and No FEAR Act phrasing. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check61 days agoChange DetectedRevision: v3.3.4 has been added, replacing v3.3.3; no study content or functionality changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to RT+Nivolumab+Ipilimumab vs RT+Capecitabine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RT+Nivolumab+Ipilimumab vs RT+Capecitabine Clinical Trial page.